Home›Companies›Biotech & Pharma›DesiCorp

DesiCorp, Inc.

DesiCorp develops medicine preservation, packaging and manufacturing solutions for healthcare organizations.

Updated Nov 10, 2026·Latest SEC filing Jun 9, 2026·Suggest an edit

About DesiCorp

DesiCorp is a private company based in Louisville, Kentucky. It has reported $8,688,529 raised in two offerings on Form D since July 2024. Its chief executive is Brett Janis.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 20, 2026Apr 1, 2026amended Jun 9, 2026$3,499,999of $6.0M target12$291KEquity, OptionsRule 506(b)Form D/A ↗1 earlier filing
Jul 3, 2024Jul 18, 2024amended Jan 20, 2026$5,188,530of $8.0M target15$345KEquityRule 506(b)Form D/A ↗2 earlier filings
Total, two offerings$8,688,529

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on DesiCorp's Form D filed Jun 9, 2026.

MM
Michael Menze
President / Co-Founder and director
JK
Jonathan Kopecheck
Executive officer and director
BJ
Brett Janis
CEO / Co-Founder and director
RS

Sources

  1. SECDesiCorp, Inc. Form D, filed Apr 1, 2026
  2. SECDesiCorp, Inc. Form D/A, filed Nov 14, 2025
  3. SECDesiCorp, Inc. Form D, filed Jul 18, 2024
  4. SECDesiCorp, Inc. filing history
  5. CompanyAbout DesiCorp